Zdrowie i gospodarka · 08/09/2023

FDA Releases Draft Guidance for Endogenous Cushing's Syndrome Treatment

The FDA is releasing a draft guidance to help pharmaceutical sponsors design clinical trials for adults with endogenous Cushing's syndrome who cannot or should not undergo surgery, in collaboration with the Division of General Endocrinology, academic experts, and the public.